Effects of Buprenorphine and Naloxone in Opiate Addicts - 4
NCT00000355 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL
Last updated 2017-01-12
Summary
The purpose of this study is to evaluate the behavioral and physiological effects of buprenorphine and naloxone, both alone and in combination.
Conditions
- Opioid-Related Disorders
- Substance-Related Disorders
Interventions
- DRUG
-
Buprenorphine
Sponsors & Collaborators
- collaborator OTHER
-
National Institute on Drug Abuse (NIDA)
lead NIH
Principal Investigators
-
Charles O'Brien, M.D., Ph.D. · PDVAMC Treatment Research Center
Study Design
- Purpose
- TREATMENT
Eligibility
- Min Age
- 21 Years
- Max Age
- 59 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 1994-11-30
- Primary Completion
- 1996-01-31
- Completion
- 1996-03-31
Countries
- United States
Study Locations
More Related Trials
-
Buprenorphine/Naloxone Treatment for Opioid Dependence-Experiment II-2 - 5
NCT00000330 ·Status: WITHDRAWN ·Phase: PHASE2
-
Buprenorphine Maintenance for Opiate Dependence - 6
NCT00000357 ·Status: COMPLETED ·Phase: PHASE2
-
Buprenorphine/Naloxone for Treatment of Opiate Dependence - 9
NCT00000344 ·Status: COMPLETED ·Phase: PHASE2
-
Abuse Potential of Buprenorphine and Naloxone in Non-Dependent Opioid Users
NCT00158236 ·Status: COMPLETED ·Phase: NA
-
Buprenorphine/Naloxone Treatment for Opioid Dependence-Experiment 1 - 1
NCT00000326 ·Status: WITHDRAWN ·Phase: PHASE2
-
Assessing Abuse Potential of Parenteral Buprenorphine/Naloxone in Non-Dependent Opioid Abusers
NCT00134875 ·Status: TERMINATED ·Phase: NA
-
Buprenorphine/Naloxone Treatment for Opioid Dependence-Experiment II-3 - 6
NCT00000331 ·Status: WITHDRAWN ·Phase: PHASE2
-
Buprenorphine Combination Tablet Feasibility - 1
NCT00000298 ·Status: COMPLETED ·Phase: PHASE2
-
Buprenorphine and Naloxone for the Treatment of Opiate Dependence - 1
NCT00015171 ·Status: COMPLETED ·Phase: PHASE3
-
Buprenorphine Pharmacology Related to Addiction Treatment - 18
NCT00000236 ·Status: COMPLETED ·Phase: PHASE2
-
Effectiveness of Buprenorphine/Naloxone
NCT02882412 ·Status: UNKNOWN
-
Efficacy of Buprenorphine and XR-Naltrexone Combination for Relapse Prevention in Opioid Use Disorder
NCT05011266 ·Status: RECRUITING ·Phase: PHASE2/PHASE3
-
Buprenorphine/Naloxone for Opiate-Dependence Treatment - 1
NCT00015028 ·Status: COMPLETED ·Phase: PHASE2
-
Buprenorphine as a Treatment for Individuals Dependent on Analgesic Opioids
NCT00218101 ·Status: COMPLETED ·Phase: PHASE2
-
Buprenorphine/Naloxone Treatment for Opioid Dependence-Experiment III) - 3
NCT00000328 ·Status: WITHDRAWN ·Phase: PHASE2
-
Buprenorphine/Naloxone Treatment for Opioid Dependence-Experiment I(2) - 2
NCT00000327 ·Status: WITHDRAWN ·Phase: PHASE2
-
Low-dose Buprenorphine Initiation for Opioid Use Disorder
NCT05450718 ·Status: RECRUITING ·Phase: PHASE4
-
Buprenorphine/Naloxone - Facilitated Rehabilitation for Opioid Dependent Adolescents - 1
NCT00078130 ·Status: COMPLETED ·Phase: PHASE3
-
Buprenorphine Treatment for Opioid Dependence
NCT02187198 ·Status: COMPLETED ·Phase: PHASE3
-
Abuse Potential of Buprenorphine/Naloxone
NCT00149539 ·Status: TERMINATED ·Phase: PHASE2
-
Buprenorphine Naltrexone-P1 A-Cocaine
NCT00733720 ·Status: COMPLETED ·Phase: PHASE1
-
Buprenorphine Induction for Fentanyl Dependent Opioid Users
NCT04794790 ·Status: WITHDRAWN ·Phase: EARLY_PHASE1
-
Buprenorphine/Naloxone in the Treatment of Heroin Dependence - 14
NCT00015340 ·Status: COMPLETED ·Phase: PHASE4
-
Buprenorphine Treatment: A Safe Alternative for Opioid Dependent Pain Patients
NCT01841931 ·Status: TERMINATED ·Phase: PHASE4
-
Induction of Opioid-Dependent Individuals Onto Buprenorphine and Buprenorphine/Naloxone
NCT00637000 ·Status: COMPLETED ·Phase: PHASE2